Tenascin-C in development and disease: gene regulation and cell function

被引:248
作者
Jones, PL
Jones, FS
机构
[1] Childrens Hosp Philadelphia, Abramson Res Ctr, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[3] Scripps Res Inst, Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA
关键词
tenascin-C; matrix metalloproteinases; integrins; biomechanics; gene promoter; homeobox genes;
D O I
10.1016/S0945-053X(00)00106-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tenascin-C (TN-C) is a modular and multifunctional extracellular matrix (ECM) glycoprotein that is exquisitely regulated during embryonic development and in adult tissue remodeling. TN-C gene transcription is controlled by intracellular signals that are generated by multiple soluble factors, integrins and mechanical forces. These external cues are interpreted by particular DNA control elements that interact with different classes of transcription factors to activate or repress TN-C expression in a cell type- and differentiation-dependent fashion. Among the transcriptional regulators of the TN-C gene that have been identified, the homeobox family of proteins has emerged as a major player. Downstream from TN-C, intracellular signals that are relayed via specific cell surface receptors often impart contrary cellular functions, even within the same cell type. A key to understanding this behavior may lie in the dual ability of TN-C-enriched extracellular matrices to generate intracellular signals, and to define unique cellular morphologies that modulate these signal transduction pathways. Thus, despite the contention that TN-C null mice appear to develop and act normally, TN-C biology continues to provide a wealth of information regarding the complex nature of the ECM in development and disease. (C) Elsevier Science B.V. International Society of Matrix Biology. All rights reserved.
引用
收藏
页码:581 / 596
页数:16
相关论文
共 176 条
[1]   Rho family small G proteins play critical roles in mechanical stress-induced hypertrophic responses in cardiac myocytes [J].
Aikawa, R ;
Komuro, I ;
Yamazaki, T ;
Zou, YZ ;
Kudoh, S ;
Zhu, WD ;
Kadowaki, T ;
Yazaki, Y .
CIRCULATION RESEARCH, 1999, 84 (04) :458-466
[2]  
AKHURST RJ, 1990, DEVELOPMENT, V108, P645
[3]   Pervasive conformational fluctuations on microsecond time scales in a fibronectin type III domain [J].
Akke, M ;
Liu, J ;
Cavanagh, J ;
Erickson, HP ;
Palmer, AG .
NATURE STRUCTURAL BIOLOGY, 1998, 5 (01) :55-59
[4]  
[Anonymous], 1997, MECH FORCES THEIR EF
[5]   H-1-NMR ASSIGNMENT AND SECONDARY STRUCTURE OF THE CELL-ADHESION TYPE-III MODULE OF FIBRONECTIN [J].
BARON, M ;
MAIN, AL ;
DRISCOLL, PC ;
MARDON, HJ ;
BOYD, J ;
CAMPBELL, ID .
BIOCHEMISTRY, 1992, 31 (07) :2068-2073
[6]   SMOOTH-MUSCLE CELL-MIGRATION AND MATRIX METALLOPROTEINASE EXPRESSION AFTER ARTERIAL INJURY IN THE RAT [J].
BENDECK, MP ;
ZEMPO, N ;
CLOWES, AW ;
GALARDY, RE ;
REIDY, MA .
CIRCULATION RESEARCH, 1994, 75 (03) :539-545
[7]  
Bergwerff M, 1998, DEV DYNAM, V213, P59, DOI 10.1002/(SICI)1097-0177(199809)213:1<59::AID-AJA6>3.0.CO
[8]  
2-X
[9]   Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: Phase I trial results [J].
Bigner, DD ;
Brown, MT ;
Friedman, AH ;
Coleman, RE ;
Akabani, G ;
Friedman, HS ;
Thorstad, WL ;
McLendon, RE ;
Bigner, SH ;
Zhao, XG ;
Pegram, CN ;
Wikstrand, CJ ;
Herndon, JE ;
Vick, NA ;
Paleologos, N ;
Cokgor, I ;
Provenzale, JM ;
Zalutsky, MR .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) :2202-2212
[10]   EXPRESSION OF DIFFERENT TENASCIN ISOFORMS IN NORMAL, HYPERPLASTIC AND NEOPLASTIC HUMAN BREAST TISSUES [J].
BORSI, L ;
CARNEMOLLA, B ;
NICOLO, G ;
SPINA, B ;
TANARA, G ;
ZARDI, L .
INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (05) :688-692